E14 and S7B Clinical and Nonclinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential--Questions and Answers (R1): Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 30, 2026
October 30, 2026
2b8e02d9-243b-42e4-93cb-b1f778759691
Related Documents
Questions and Answers on Biosimilar Development and the BPCI Act: Guidance for Industry
Guidance DocumentOctober 9, 2026Center for Drug Evaluation and Research
Q8, Q9, and Q10 Questions and Answers (R5)
Guidance DocumentMay 29, 2026Center for Drug Evaluation and Research
E14 and S7B Clinical and Nonclinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential--Questions and Answers : Guidance for Industry
Guidance DocumentAugust 26, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.